Your browser doesn't support javascript.
loading
Reply: Niacin therapy improves outcome and normalizes metabolic abnormalities in an NAXD-deficient patient.
Van Bergen, Nicole J; Walvekar, Adhish S; Linster, Carole L; Christodoulou, John.
Affiliation
  • Van Bergen NJ; Brain and Mitochondrial Research Group, Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Australia.
  • Walvekar AS; Department of Paediatrics, University of Melbourne, Melbourne, Australia.
  • Linster CL; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux L-4367, Luxembourg.
  • Christodoulou J; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux L-4367, Luxembourg.
Brain ; 145(5): e41-e42, 2022 06 03.
Article in En | MEDLINE | ID: mdl-35254397
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Niacin Limits: Humans Language: En Journal: Brain Year: 2022 Type: Article Affiliation country: Australia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Niacin Limits: Humans Language: En Journal: Brain Year: 2022 Type: Article Affiliation country: Australia